These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8264290)

  • 1. [Sodium channels and anti-arrhythmia agents. Time for a new classification?].
    Elinder F; Arhem P
    Lakartidningen; 1993 Dec; 90(50):4545-9. PubMed ID: 8264290
    [No Abstract]   [Full Text] [Related]  

  • 2. [New classification of anti-arrhythmia agents according to the effects on ion channels].
    Hiraoka M
    Nihon Naika Gakkai Zasshi; 1991 Dec; 80(12):1975-80. PubMed ID: 1725177
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-arrhythmia agents: classification, mode of action, and therapeutic usefulness].
    Tamargo J; Delpón E; Valenzuela C; Pérez O
    Rev Clin Esp; 1993 Mar; 192(4):189-96. PubMed ID: 8386844
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist].
    Tamargo J; Valenzuela C; Delpón E
    Rev Esp Cardiol; 1993 Mar; 46(3):183-94. PubMed ID: 8387683
    [No Abstract]   [Full Text] [Related]  

  • 5. Shortcomings of the present classification system of anti-arrhythmic drugs.
    Weirich J; Antoni H
    Eur Heart J; 1992 Jun; 13(6):862-3. PubMed ID: 1320569
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modulated receptor hypothesis of action of antiarrhythmic drugs].
    Inoue H; Sugimoto T
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1917-24. PubMed ID: 2173035
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantification of state-dependent drug interactions with the sodium channel.
    Sheridan RD
    Br J Pharmacol; 2000 Jan; 129(2):409-11. PubMed ID: 10694250
    [No Abstract]   [Full Text] [Related]  

  • 8. Symposium: pharmacology of class I anti-arrhythmic agents. Introduction: electrophysiological, biochemical and clinical considerations.
    Man RY
    Clin Invest Med; 1991 Oct; 14(5):444-6. PubMed ID: 1660366
    [No Abstract]   [Full Text] [Related]  

  • 9. The Sicilian Gambit and antiarrhythmic drug development.
    Colatsky TJ
    Cardiovasc Res; 1992 Jun; 26(6):562-5. PubMed ID: 1333361
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent development of anti-arrhythmia agents and their adverse effects].
    Inoue H
    Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1073-9. PubMed ID: 1680944
    [No Abstract]   [Full Text] [Related]  

  • 11. Putting the Sicilian Gambit to the test.
    Janse MJ
    Eur Heart J; 1992 Nov; 13 Suppl F():30-7. PubMed ID: 1335870
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacology and classification of anti-arrhythmia agents].
    Giudicelli JF; Lhoste F
    Rev Prat; 1975 Oct; 25(45):3449-52, 3455-8. PubMed ID: 1209115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preclinical study of anti-arrhythmia agents. Classification].
    Dupuis B; Caron J
    Rev Prat; 1986 Nov; 36(53):3109-14. PubMed ID: 3809929
    [No Abstract]   [Full Text] [Related]  

  • 14. [The mechanism of antiarrhythmic action of a new ammonium derivative of lidocaine (LKhT-12-02)].
    Blinov DS; Balashov VP; Sernov LN; Kazachenko VN; Blinova EV; Belova LA; Astashev ME
    Eksp Klin Farmakol; 2006; 69(6):31-3. PubMed ID: 17209461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Classification of anti-arrhythmia agents and their characteristics].
    Hayakawa H
    Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1022-5. PubMed ID: 1680943
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of oxyphenamone on sodium and calcium channels of guinea pig myocardial cells].
    Fan LL; Song Z; Wang TY
    Yao Xue Xue Bao; 2004 Jun; 39(6):410-4. PubMed ID: 15491095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present classification of anti-arrhythmia agents].
    Hashimoto K
    Nihon Rinsho; 1985 Nov; 43(11):2243-7. PubMed ID: 4087403
    [No Abstract]   [Full Text] [Related]  

  • 18. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proposals for a new grouping of anti-arrhythmia agents (use of an electrophysiologic method for the direct study in man)].
    Domenichelli B; Manzoli U; Feraco E; Schiavoni G
    Boll Soc Ital Cardiol; 1973; 18(9):877-85. PubMed ID: 4807173
    [No Abstract]   [Full Text] [Related]  

  • 20. Discussion of "Why do some drugs preferentially block open sodium channels?": consideration of other significant factors in the binding process.
    Rhodes DG; Herbette LG
    J Mol Cell Cardiol; 1988 Jun; 20(6):571-2. PubMed ID: 2851056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.